{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:20:56Z","timestamp":1790572856838,"version":"4.1.0"},"reference-count":50,"publisher":"China Science Publishing & Media Ltd.","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81371221"],"award-info":[{"award-number":["81371221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30970986"],"award-info":[{"award-number":["30970986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"New Century Excellent Talents in University","award":["NCET-11-1084"],"award-info":[{"award-number":["NCET-11-1084"]}]},{"name":"Chongqing Education Commission Science and Technology Research Project","award":["KJ1500231"],"award-info":[{"award-number":["KJ1500231"]}]},{"name":"Basic Medicine School of Chongqing Medical University","award":["JC201510"],"award-info":[{"award-number":["JC201510"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2016,10,1]]},"DOI":"10.1093\/abbs\/gmw085","type":"journal-article","created":{"date-parts":[[2016,9,11]],"date-time":"2016-09-11T00:18:20Z","timestamp":1473553100000},"page":"930-938","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":25,"title":["Gender difference in valproic acid-induced neuroprotective effects on APP\/PS1 double transgenic mice modeling Alzheimer's disease"],"prefix":"10.3724","volume":"48","author":[{"given":"Zhimin","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqiong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","volume":"56","author":"Castellani RJ","year":"2010","unstructured":"Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon, 2010, 56: 484-546.","journal-title":"Dis Mon"},{"key":"null","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/CCLM.2011.087","volume":"49","author":"Prvulovic D","year":"2011","unstructured":"Prvulovic D, Hampel H. Amyloid \u03b2 (A\u03b2) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Clin Chem Lab Med, 2011, 49: 367-374.","journal-title":"Clin Chem Lab Med"},{"key":"null","first-page":"148","volume":"2012","author":"Dye RV","year":"2012","unstructured":"Dye RV, Miller KJ, Singer EJ, Levine AJ. Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis, 2012, 2012: 148-155.","journal-title":"Int J Alzheimers Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1037\/a0012838","volume":"23","author":"Proust-Lima C","year":"2008","unstructured":"Proust-Lima C, Amieva H, Letenneur L, Orgogozo JM, Jacqmin-Gadda H, Dartigues JF. Author information. Gender and education impact on brain aging: a general cognitive factor approach. Psychol Aging, 2008, 23: 608-620.","journal-title":"Psychol Aging"},{"key":"null","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)64064-3","volume":"158","author":"Callahan MJ","year":"2001","unstructured":"Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol, 2001, 158: 1173-1177.","journal-title":"Am J Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"Barnes LL","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry, 2005, 62: 685-691.","journal-title":"Arch Gen Psychiatry"},{"key":"null","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1196\/annals.1297.005","volume":"1019","author":"Corder EH","year":"2004","unstructured":"Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci, 2004, 1019: 24-28.","journal-title":"Ann N Y Acad Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000314681","volume":"30","author":"Phung TK","year":"2010","unstructured":"Phung TK, Waltoft BL, Laursen TM, Settnes A, Kessing LV, Mortensen PB, Waldemar G. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord, 2010, 30: 43-50.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"null","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/417292a","volume":"417","author":"Williams RS","year":"2002","unstructured":"Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature, 2002, 417: 292-295.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","volume":"11","author":"Chen PS","year":"2006","unstructured":"Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B. Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry, 2006, 11: 1116-1125.","journal-title":"Mol Psychiatry"},{"key":"null","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainresbull.2011.03.006","volume":"85","author":"Hu JP","year":"2011","unstructured":"Hu JP, Xie JW, Wang CY, Wang T, Wang X, Wang SL, Teng WP. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways. Brain Res Bull, 2011, 85: 194-200.","journal-title":"Brain Res Bull"},{"key":"null","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cns.12186","volume":"20","author":"Wang Z","year":"2014","unstructured":"Wang Z, Zhang XJ, Li T, Li J, Tang Y, Le W. Valproic acid reduces neuritic plaque formation and improves learning deficits in APP Swe\/PS1 A246E transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin. CNS Neurosci Ther, 2014, 20: 209-217.","journal-title":"CNS Neurosci Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"Phiel CJ","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem, 2001, 276: 36734-36741.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"Kim HJ","year":"2007","unstructured":"Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther, 2007, 321: 892-901.","journal-title":"J Pharmacol Exp Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10571-013-0012-y","volume":"34","author":"Yao ZG","year":"2014","unstructured":"Yao ZG, Liang L, Liu Y, Zhang L, Zhu H, Huang L, Qin C. Valproate improves memory deficits in an Alzheimer's disease mouse model: investigation of possible mechanisms of action. Cell Mol Neurobiol, 2014, 34: 805-812.","journal-title":"Cell Mol Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","volume":"51","author":"Xuan AG","year":"2015","unstructured":"Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH, Hong LP. Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease. Mol Neurobiol, 2015, 51: 300-312.","journal-title":"Mol Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","volume":"7","author":"Jope RS","year":"2006","unstructured":"Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets, 2006, 7: 1421-1434.","journal-title":"Curr Drug Targets"},{"key":"null","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","volume":"45","author":"DaRocha-Souto B","year":"2012","unstructured":"DaRocha-Souto B, Coma M, P\u00e9rez-Nievas BG, Scotton TC, Siao M, S\u00e1nchez-Ferrer P, Hashimoto T. Activation of glycogen synthase kinase-3 beta mediates beta-amyloid induced neuritic damage in Alzheimer's disease. Neurobiol Dis, 2012, 45: 425-437.","journal-title":"Neurobiol Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0035-3787(06)75098-6","volume":"162","author":"Muyllaert D","year":"2006","unstructured":"Muyllaert D, Terwel D, Borghgraef P, Devijver H, Dewachter I, Van Leuven F. Transgenic mouse models for Alzheimer's disease: the role of GSK-3\u03b2 in combined amyloid and tau-pathology. Rev Neurol (Paris), 2006, 162: 903-907.","journal-title":"Rev Neurol (Paris)"},{"key":"null","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2174\/138161210793176581","volume":"16","author":"Medina M","year":"2010","unstructured":"Medina M, Avila J. Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease. Curr Pharm Des, 2010, 16: 2790-2798.","journal-title":"Curr Pharm Des"},{"key":"null","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1074\/jbc.M605178200","volume":"282","author":"Liang MH","year":"2007","unstructured":"Liang MH, Chuang DM. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J Biol Chem, 2007, 282: 3904-3917.","journal-title":"J Biol Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","volume":"79","author":"Beurel E","year":"2006","unstructured":"Beurel E, Jope RS. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol, 2006, 79: 173-189.","journal-title":"Prog Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jnr.22563","volume":"89","author":"Zhang Z","year":"2011","unstructured":"Zhang Z, Zhao R, Qi J, Wen S, Tang Y, Wang D. Inhibition of glycogen synthase kinase-3beta by Angelica sinensis extract decreases beta-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons. J Neurosci Res, 2011, 89: 437-447.","journal-title":"J Neurosci Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"Qing H","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z. Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med, 2008, 205: 2781-2789.","journal-title":"J Exp Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1567205011310030005","volume":"10","author":"Long Z","year":"2013","unstructured":"Long Z, Zheng M, Zhao L, Xie P, Song C, Chu Y, Song W, He G. Valproic acid attenuates neuronal loss in the brain of APP\/PS1 double transgenic Alzheimer's disease mice model. Curr Alzheimer Res, 2013, 10: 261-269.","journal-title":"Curr Alzheimer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/cns.12445","volume":"21","author":"Long Z","year":"2015","unstructured":"Long Z, Zhao L, Jiang R, Wang K, Luo S, Zheng M, Li X. Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase 3\u03b2 signaling pathway in an Alzheimer's disease model. CNS Neurosci Ther, 2015, 21: 887-897.","journal-title":"CNS Neurosci Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000087505","volume":"75","author":"Grikiniene J","year":"2005","unstructured":"Grikiniene J, Stakisaitis D, Tschaika M. Influence of sodium valproate on sodium and chloride urinary excretion in rats, gender differences. Pharmacology, 2005, 75: 111-115.","journal-title":"Pharmacology"},{"key":"null","first-page":"935","volume":"40","author":"Grikiniene J","year":"2004","unstructured":"Grikiniene J, Volbekas null, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas), 2004, 40: 935-942.","journal-title":"Medicina (Kaunas)"},{"key":"null","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF01181321","volume":"22","author":"Itarat W","year":"1993","unstructured":"Itarat W, Jones DG. Morphological characteristics of perforated synapses in the latter stages of synaptogenesis in rat neocortex: stereological and three-dimensional approaches. J Neurocytol, 1993, 22: 753-764.","journal-title":"J Neurocytol"},{"key":"null","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"Bertram L","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron, 2010, 68: 270-281.","journal-title":"Neuron"},{"key":"null","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cbpa.2009.04.619","volume":"13","author":"Bolognesi ML","year":"2009","unstructured":"Bolognesi ML, Matera R, Minarini A, Rosini M, Melchiorre C. Melchiorre, Alzheimer's disease: new approaches to drug discovery. Curr Opin Chem Biol, 2009, 13: 303-308.","journal-title":"Curr Opin Chem Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1745-7254.2008.00752.x","volume":"29","author":"Ji HF","year":"2008","unstructured":"Ji HF, Zhang HY. Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacol Sin, 2008, 29: 143-151.","journal-title":"Acta Pharmacol Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.297.5585.1260","volume":"297","author":"Helmuth L","year":"2002","unstructured":"Helmuth L. New therapies. New Alzheimer's treatments that may ease the mind. Science, 2002, 297: 1260-1262.","journal-title":"Science"},{"key":"null","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0014-5793(03)00350-8","volume":"542","author":"Jeong MR","year":"2003","unstructured":"Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS, Chuang DM. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett, 2003, 542: 74-78.","journal-title":"FEBS Lett"},{"key":"null","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","volume":"81","author":"Zhang XZ","year":"2010","unstructured":"Zhang XZ, Li XJ, Zhang HY. Valproic acid as a promising agent to combat Alzheimer's disease. Brain Res Bull, 2010, 81: 3-6.","journal-title":"Brain Res Bull"},{"key":"null","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1124\/mol.104.009308","volume":"67","author":"Eickholt BJ","year":"2005","unstructured":"Eickholt BJ, Towers GJ, Ryves WJ, Eikel D, Adley K, Ylinen LM, Chadborn NH. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol, 2005, 67: 1426-1433.","journal-title":"Mol Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Leng Y","year":"2006","unstructured":"Leng Y, Chuang DM. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci, 2006, 26: 7502-7512.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.pbb.2007.02.010","volume":"86","author":"Swiergiel AH","year":"2007","unstructured":"Swiergiel AH, Dunn AJ. Effects of interleukin-1\u03b2 and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav, 2007, 86: 651-659.","journal-title":"Pharmacol Biochem Behav"},{"key":"null","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1460-9568.2008.06485.x","volume":"28","author":"Maren S","year":"2008","unstructured":"Maren S. Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur J Neurosci, 2008, 28: 1661-1666.","journal-title":"Eur J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2011.05.067","volume":"189","author":"Liu CC","year":"2011","unstructured":"Liu CC, Crone NE, Franaszczuk PJ, Cheng DT, Schretlen DS, Lenz FA. Fear conditioning is associated with dynamic directed functional interactions between and within the human amygdala, hippocampus, and frontal lobe. Neuroscience, 2011, 189: 359-369.","journal-title":"Neuroscience"},{"key":"null","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nn.2709","volume":"14","author":"D'Amelio M","year":"2011","unstructured":"D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci, 2011, 14: 69-76.","journal-title":"Nat Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"de Calignon A","year":"2010","unstructured":"de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT. Caspase activation precedes and leads to tangles. Nature, 2010, 464: 1201-1204.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"Scheff SW","year":"2007","unstructured":"Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology, 2007, 68: 1501-1508.","journal-title":"Neurology"},{"key":"null","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","volume":"33","author":"Citri A","year":"2008","unstructured":"Citri A, Malenka RC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology, 2008, 33: 18-41.","journal-title":"Neuropsychopharmacology"},{"key":"null","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.biopsych.2009.11.008","volume":"67","author":"Sgobio C","year":"2010","unstructured":"Sgobio C, Ghiglieri V, Costa C, Bagetta V, Siliquini S, Barone I, Di Filippo M. Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. Biol Psychiatry, 2010, 67: 567-574.","journal-title":"Biol Psychiatry"},{"key":"null","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0074-7742(09)00408-5","volume":"84","author":"Luque FA","year":"2009","unstructured":"Luque FA, Jaffe SL. The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview. Int Rev Neurobiol, 2009, 84: 151-165.","journal-title":"Int Rev Neurobiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","volume":"26","author":"Deshpande A","year":"2006","unstructured":"Deshpande A, Mina E, Glabe C, Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci, 2006, 26: 6011-6018.","journal-title":"J Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-150696","volume":"50","author":"Hatami A","year":"2015","unstructured":"Hatami A, Monjazeb S, Glabe C. The anti-amyloid-\u03b2 monoclonal antibody 4G8 recognizes a generic sequence-independent epitope associated with \u03b1-Synuclein and islet amyloid polypeptide amyloid fibrils. J Alzheimers Dis, 2015, 50: 517-525.","journal-title":"J Alzheimers Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cns.12186","volume":"20","author":"Wang Z","year":"2014","unstructured":"Wang Z, Zhang XJ, Li T, Li J, Tang Y, Le W. Valproic acid reduces neuritic plaque formation and improves learning deficits in APP Swe\/PS1 A246E, transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin. CNS Neurosci Ther, 2014, 20: 209-217.","journal-title":"CNS Neurosci Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","volume":"46","author":"Nalivaeva NN","year":"2011","unstructured":"Nalivaeva NN, Belyaev ND, Lewis DI, Pickles AR, Makova NZ, Bagrova DI, Dubrovskaya NM. Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J Mol Neurosci, 2011, 46: 569-577.","journal-title":"J Mol Neurosci"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/EBE3E30C2D2147BBBCF508B74E8F2C19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmw085","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/EBE3E30C2D2147BBBCF508B74E8F2C19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T02:05:37Z","timestamp":1692497137000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmw085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,1]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmw085","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,1]]}}}